Today, Triall announces the official release of the 2.0 version of the Triall whitepaper! This new version reflects our latest insights, plans, and vision for building towards the world’s first,...Read More
Last week, Triall featured on Cointelegraph China. The article, written by Chinese journalist Anderson Li, explains how Triall aims to tackle some of the persistent issues currently felt by the...Read More
Last week, Triall presented at the Utrecht Blockchain Nights to discuss the relevance of blockchain-based mechanisms for clinical trials and international cooperation during infectious disease outbreaks. The night was hosted by Lisk...Read More
Triall announces that it has joined the Pistoia Alliance, a not-for-profit members’ organization that works to lower barriers to innovation in the Life Sciences and healthcare research and development (R&D)...Read More
Triall announces that its first software solution ‘Verial eTMF’ has successfully passed the pilot stage and is now being onboarded and used in multiple clinical trial consortia. In summer 2019,...Read More
Triall today announces that it has officially partnered with Dizer Capital, a private equity firm focused on startups in the technology sector. The investment provided by Dizer Capital will enable...Read More
Allan Bukuya has joined the Triall initiative as Advisor eClinical Solutions. He brings two decades of experience in clinical research and in-depth understanding of the Pharma, CRO and eClinical industries....Read More
Danielle Bradbury will join the Triall initiative as advisor Quality and Compliance. She has over 20 years of experience in clinical research and has extensive knowledge of SOP management, GxP...Read More
Sina Djali will join the ranks of the Triall initiative as advisor Clinical Trial Data Analytics. Sina has over 25 years of experience in drug and clinical development in various...Read More
We are excited to announce the world’s first clinical trial on the blockchain. A beta version of the foundation’s Verial software application was given green light for use in a real-world...Read More
